Rett syndrome

Last updated: November 01, 2022

Rett syndrome

HMBP

HMBP

Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Gene regulation
Epigenetics
Amino acids and protein folding
DNA replication
DNA damage and repair
Cell cycle
DNA mutations
Cellular structure and function
Introduction to pharmacology
Enzyme function
Pharmacodynamics: Agonist, partial agonist and antagonist
Human development days 1-4
Human development week 2
Human development days 4-7
Human development week 3
Ectoderm
Mesoderm
Endoderm
Ionic bonding
Covalent bonding
Physiologic pH and buffers
Buffering and Henderson-Hasselbalch equation
Acid-base disturbances: Pathology review
Electron transport chain and oxidative phosphorylation
Glycogen metabolism
Pentose phosphate pathway
Gluconeogenesis
Cell membrane
Cytoskeleton and intracellular motility
Selective permeability of the cell membrane
Cell signaling pathways
Mitosis and meiosis
Light microscopy and staining methods
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Arsenic poisoning
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Independent assortment of genes and linkage
Inheritance patterns
Drug administration and dosing regimens
Cholesterol metabolism
Ketone body metabolism
Fatty acid synthesis
Nitrogen and urea cycle
Amino acid metabolism
Protein structure and synthesis
Nucleotide metabolism
Gout
Gout and pseudogout: Pathology review
Severe combined immunodeficiency
Fatty acid oxidation
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
ELISA (Enzyme-linked immunosorbent assay)
Gel electrophoresis and genetic testing
Karyotyping
Fluorescence in situ hybridization
Citric acid cycle
Glycolysis
Carbohydrates and sugars
Cystinosis
Friedreich ataxia
Achondroplasia
Niemann-Pick disease type C
Gaucher disease (NORD)
Fabry disease (NORD)
Niemann-Pick disease types A and B (NORD)
Krabbe disease
Adrenoleukodystrophy (NORD)
Fragile X syndrome
Cystinuria (NORD)
Hartnup disease
Lesch-Nyhan syndrome
Rett syndrome
Ataxia-telangiectasia
DiGeorge syndrome
Myasthenia gravis
Charcot-Marie-Tooth disease
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Tay-Sachs disease (NORD)
Cystic fibrosis
Williams syndrome
Cri du chat syndrome
Angelman syndrome
Prader-Willi syndrome
Turner syndrome
Patau syndrome (Trisomy 13)
Edwards syndrome (Trisomy 18)
Down syndrome (Trisomy 21)
Fanconi anemia
Xeroderma pigmentosum
Osteogenesis imperfecta
Marfan syndrome
Ehlers-Danlos syndrome
Primary ciliary dyskinesia
Disorders of carbohydrate metabolism: Pathology review
Glycogen storage disorders: Pathology review
Glycogen storage disease type II (NORD)
Glycogen storage disease type IV
Glycogen storage disease type V
Glycogen storage disease type III
Glycogen storage disease type I
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Galactosemia
Essential fructosuria
Pyruvate dehydrogenase deficiency
Hereditary fructose intolerance
Proteins

Transcript

Watch video only

Rett syndrome is a rare neurological disorder that mostly in young girls and causes severe impairments in their ability to talk, walk, eat, and even breathe.

A classic feature is that children often make repetitive hand movements - like flapping their hands or clasping their hands together tightly.

The disease was named after Dr. Andreas Rett, a pediatrician who discovered the syndrome in the 1960s.

To begin, the brain is composed of billions of interconnected neurons, each of which is made of up dendrites, that receive signals from other neurons, the soma, or cell body, which has all of the neuron’s main organelles, and the axon which sends signals to other neurons.

In Rett syndrome there’s an X-linked autosomal dominant mutation of the Methyl-CpG-binding protein 2 gene, or MECP2 gene, which codes for MeCP2 protein.

The mutation in the MECP2 gene usually occurs sporadically, meaning that it’s usually not inherited from a parent.

It’s thought that the MeCP2 protein helps to silence or turn off other genes.

Males have only one X chromosome, so if there’s a mutation in the MECP2 gene, then they cannot make functional MeCP2 protein, and that might be why males with the mutation typically die in utero or shortly after birth.

Very rarely a male with Klinefelter syndrome, where there’s an XXY set of chromosomes, might develop Rett syndrome.

Females have 2 X chromosomes, however, so one mutated MECP2 gene can be compensated for by a normal MeCP2 gene on the other X chromosome.

The genes that are regulated by MeCP2 proteins are particularly important for brain development, specifically to help establish neuronal connections.

So in young girls, when they’re first born, the low levels of MeCP2 proteins are sufficient for normal brain development. But as the brain grows more complex, the level of MeCP2 becomes insufficient and the brain fails to develop normally.

In addition to neurologic effects, Rett syndrome is also associated with prolonged QT syndrome, which is when it takes longer than usual for the heart to repolarize.

Rett syndrome can be thought of in four main stages.

The first stage is the early onset stage and occurs between ages 6 to 18 months.

Before 6 months of age, children with Rett syndrome develop normally, but starting around 6 months, children start to lose interest in play and no longer maintain eye contact.

The second stage is the rapid deterioration stage and occurs between ages 1 to 4 years. In this stage there is a dramatic regressions in speech and motor skills.

Key Takeaways

Rett syndrome, originally termed cerebroatrophic hyperammonemia, is a rare genetic neurological disorder of the gray matter of the brain that almost exclusively affects females, though it has also been found in male patients. It is caused by a mutation of the MECP2 gene and is inherited in an X-linked dominant pattern.

The symptoms of Rett syndrome typically appear between 6 and 18 months of age and include slowed growth, loss of language and social skills, and the development of repetitive hand movements. Other symptoms can include seizures, scoliosis, and breathing abnormalities.

The diagnosis of Rett syndrome is based on a genetic test looking for the MECP2 mutation, and the treatment focuses on managing symptoms with selective serotonin reuptake inhibitors (SSRIs) to help manage behavioral issues. Additionally, a multidisciplinary team that includes occupational, speech, and physical therapists can help optimize a child's life.